A-192621 CAS No.195529-54-5
A-192621 CAS No.195529-54-5
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1962 | 5mg | 280.00 | + Add to cart |
|
| R-R-1962 | 10mg | 460.00 | + Add to cart |
|
|
|
||||
Product description
A-192621/CAS No.195529-54-5 is a potent, nonpeptide, orally active and selective endothelin B (ETB) receptor antagonist with an IC50 of 4.5 nM and a Ki of 8.8 nM. The selectivity of A-192621 is 636-fold higher than ETA (IC50 of 4280 nM and Ki of 5600 nM). A-192621 promotes apoptosis in PASMCs. A-192621 alos causes elevation of arterial blood pressure and an elevation in the plasma ET-1 level.
| Appearance | N/A |
|---|---|
| Molecular Weight | 558.66 |
| Purity | >90% |
| CAS | 195529-54-5 |
| Formula | C33H38N2O6 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of A-192621 CAS No.195529-54-5
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


